peritonectomy procedures
Recently Published Documents


TOTAL DOCUMENTS

21
(FIVE YEARS 2)

H-INDEX

12
(FIVE YEARS 1)

2019 ◽  
Vol 36 (1) ◽  
pp. 743-751
Author(s):  
Frédéric Mercier ◽  
Faheez Mohamed ◽  
Jean-Baptiste Cazauran ◽  
Vahan Kepenekian ◽  
Delphine Vaudoyer ◽  
...  

2018 ◽  
Vol 3 (1) ◽  
Author(s):  
Jan Franko

AbstractTreatment choices for colorectal peritoneal carcinomatosis/metastases include systemic therapy and increasingly cytoreductive surgery with intraperitoneal chemotherapy delivery. These options are best considered as complementary and not exclusive alternatives. Two prospective randomized trials support use of peritonectomy procedures and intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis. This overview examines efficacy, limitations and landscape of systemic therapy focusing on colorectal peritoneal carcinomatosis. Observations from literature support notions that (1) systemic therapy provides survival benefit for all prototypical patients with mCRC irrespective of metastatic disease site; (2) the magnitude of this benefit is considerably reduced among patients with peritoneal metastases who consequently experience significantly shorter overall survival; (3) efficacy of systemic therapy improved over time but at a slower pace for those with carcinomatosis; (4) this therapeutic difference has not diminished with introduction of targeted therapy, but perhaps widened; (5) further research of cytoreductive surgery and/or intraperitoneal regional therapies is thus a multidisciplinary responsibility of the entire oncology community; (6) peritonectomy procedures with intraperitoneal regional therapy are not scientifically supported in absence of systemic therapies.


Author(s):  
Angelo Di Giorgio ◽  
Daniele Biacchi ◽  
Antonio Ciardi ◽  
Alessio Impagnatiello ◽  
Maurizio Cardi ◽  
...  

2016 ◽  
Vol 7 (2) ◽  
pp. 139-151 ◽  
Author(s):  
Sanket S. Mehta ◽  
Aditi Bhatt ◽  
Olivier Glehen

2016 ◽  
Vol 42 (2) ◽  
pp. 224-233 ◽  
Author(s):  
F.C. Muñoz-Casares ◽  
F.J. Medina-Fernández ◽  
Á. Arjona-Sánchez ◽  
Á. Casado-Adam ◽  
J.M. Sánchez-Hidalgo ◽  
...  

2012 ◽  
Vol 2012 ◽  
pp. 1-6 ◽  
Author(s):  
Sara Näslund Andréasson ◽  
Haile Mahteme ◽  
Bo Sahlberg ◽  
Helena Anundi

Objective. This study identified and quantified polycyclic aromatic hydrocarbons (PAHs) in electrocautery smoke during 40 peritonectomy procedures and investigated any correlations and/or differences between levels of PAHs and perioperative variables.Methods. PAHs were measured in personal and stationary sampling by 40 mm Millipore cassettes, for adsorption of both gaseous and particle-bound PAHs.Results. All 16 USEPA priority pollutant PAHs were detected during peritonectomy procedures, naphthalene being the most abundant. For the only two PAHs with Swedish occupational exposure limits (OELs), benzo[a]pyrene and naphthalene, limits were never exceeded. Amount of bleeding was the only perioperative variable that correlated with levels of PAHs.Conclusions. Low levels of PAHs were detected in electrocautery smoke during peritonectomy procedures, and an increased amount of bleeding correlated with higher levels of PAHs. For evaluation of long-term health effects, more studies are needed.


Sign in / Sign up

Export Citation Format

Share Document